The global Legionella Testing Market size was valued at USD 241.5 million in 2021 and is poised to grow at a significant CAGR of 9.7% during the forecast period 2022-28. Advances in technology, rising industry demand for accurate and timely diagnosis of Legionella and related illnesses, and unexplored potential in new countries all present favorable growth opportunities. Rapid advances in diagnostic procedures are often gaining popularity, and their demand is expected to boost the global Legionella Testing Market forward. Limited disease knowledge, a lack of adequate diagnostic infrastructure, and slow acceptance of new diagnostic methods with high costs, such as real-time PCR, are primary issues limiting market growth in these countries.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/legionella-testing-market/

Urinary Antigen Test (UAT) Segment Dominates the Legionella Testing Market
Urinary Antigen Test (UAT) is a diagnostic test that offers quick results, usually the same day. Furthermore, unlike culture-based testing, Urinary Antigen Test is not resource-intensive and technically demanding. Because UAT does not require respiratory fluid samples, sensitivity concerns are avoided. Due to significant advantages such as detecting complete serogroups connected to legionella and speedy testing, this test sector is expected to grow rapidly during the projection period. This is the most common laboratory test for detecting legionella bacteria in urine.

North America Leads Legionella Testing Market
North America will lead the market's growth during the forecast period due to the region's expanding senior population, expanded penetration of Legionella testing products via a global distribution network, and increased disposable income.   In North America, the United States is the most critical market for legionella testing. Furthermore, the increased prevalence of legionella-based illnesses, as well as advances in immunodiagnostic technologies and automation, are driving the global legionella testing market. Asia-Pacific is expected to rise swiftly.  China, India, and other developing economies will also contribute to the global legionella testing market.

The global legionella testing market is segmentation

• By Test Type: Culture Method, Urinary Antigen Test (UAT), Direct Fluorescent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other Test Types
• By Application: Water Testing, IVD Testing
• By End User: Diagnostic Laboratories, Hospital, and Clinics, Others

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=23323                                                                                                                                                                                                                           

Key players’ profiles in the legionella testing market report are bioMérieux SA, BD, Aquacert Ltd, Abbott, Bio-Rad Laboratories, Inc, IDEXX Corporation, Eiken Chemical Co., Ltd, Quidel Corporation.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights| Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747